Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-034177

Options or other derivatives

  • Chief Medical Officer acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Horn Patrick Taylor Chief Medical Officer 2024-03-18 Grant or award · Stock Option (right to buy) +400,000 400,000 D
Loading xslF345X05/ownership.xml…